Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 280–280 | Cite as

Temozolomide/vemurafenib

Hepatitis, rash and minimal hair loss: case report
Case report
  • 10 Downloads

Reference

  1. Abadal KB, et al. Eleven month progression-free survival on vemurafenib monotherapy in a patient with recurrent and metastatic BRAF V600E-mutated glioblastoma WHO grade 4. JCO Precision Oncology 2017: No. 1, 2017. Available from: URL: http://doi.org/10.1200/PO.17.00055 - USA

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations